SCHEMBL6408451

SCHEMBL6408451

COC(=O)NC(CCN1CCC2(CC1)CCN(Cc1ccc(OC)cc1)C2=O)c1ccccc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 2/20 0.42
ALDH1A1 P00352 2/20 0.41
SIGMAR1 Q99720 4/20 0.40
DRD2 P14416 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
MAPK1 P28482 1/20 0.39
ALOX15 P16050 1/20 0.39
MMP1 P03956 3/20 0.38
MMP13 P45452 3/20 0.38
MMP9 P14780 2/20 0.38
ADAM17 P78536 2/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CXCR4 P61073 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6408449 0.99 CCR5 (0.41) CCR5ALDH1A1SIGMAR1DRD2HTR2A
SCHEMBL6410779 0.93 KMT2A (0.42) CCR5ALDH1A1SIGMAR1DRD2HTR2A
SCHEMBL6415166 0.93 ALDH1A1 (0.40) CCR5ALDH1A1SIGMAR1DRD2HTR2A
Hydrochloric Acid SCHEMBL6410773 0.93 MEN1 (0.41) CCR5ALDH1A1SIGMAR1DRD2HTR2A
SCHEMBL6410561 0.92 ALDH1A1 (0.41) CCR5ALDH1A1SIGMAR1DRD2HTR2A
Hydrochloric Acid SCHEMBL6410554 0.91 SIGMAR1 (0.42) CCR5ALDH1A1SIGMAR1DRD2HTR2A
Hydrochloric Acid SCHEMBL6411300 0.91 CCR5 (0.41) CCR5ALDH1A1SIGMAR1DRD2HTR2A
Hydrochloric Acid SCHEMBL5249665 0.91 CCR5 (0.49) CCR5ALDH1A1SIGMAR1DRD2HTR2A
Hydrochloric Acid SCHEMBL6408497 0.91 CCR5 (0.42) CCR5ALDH1A1SIGMAR1DRD2HTR2A
Hydrochloric Acid SCHEMBL6412841 0.90 CCR5 (0.42) CCR5ALDH1A1SIGMAR1DRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity VIROCHEM PHARMA INC (CA) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity CXCR1, CXCR4, CXCR2 CCR5 4/4885ALDH1A1 869/4885SIGMAR1 277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.